• Fragile X, FMR1 Gene Mutation Analysis
  • Alkaline Phosphatase Isoenzymes
  • Cancer of unknown primary site
  • G6PC (Glucose-6-phosphatase, Catalytic Subunit), Glycogen Storage Disease Type 1 (von Gierke Disease) Gene Mutation Analysis
  • Homovanillic Acid (HVA), 24 Hour, Urine
  • Coccidioides Antibody, IgG and IgM
  • Rapid Plasma Reagin (RPR), CSF
  • Hepatitis B Virus (HBV) Antibody Panel for Acute and Chronic Infection
  • Colorado Tick Fever Virus Ab, IFA
  • Bacterial Culture, Upper Respiratory
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Interpretation
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.